These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 18777189

  • 41. Radioembolization with 90Y microspheres: angiographic and technical considerations.
    Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R.
    Cardiovasc Intervent Radiol; 2007; 30(4):571-92. PubMed ID: 17516113
    [Abstract] [Full Text] [Related]

  • 42. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
    Memon K, Lewandowski RJ, Riaz A, Salem R.
    Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023
    [Abstract] [Full Text] [Related]

  • 43. Red Flags, Pitfalls, and Cautions in Y90 Radiotherapy.
    Klimkowski S, Baker JC, Brown DB.
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):63-69. PubMed ID: 31079712
    [Abstract] [Full Text] [Related]

  • 44. Radioembolization of liver tumors with yttrium-90 microspheres.
    Ahmadzadehfar H, Biersack HJ, Ezziddin S.
    Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679
    [Abstract] [Full Text] [Related]

  • 45. Radioembolization with 90Y microspheres: technical considerations.
    Salem R.
    J Vasc Interv Radiol; 2007 Nov; 18(11):1460-1. PubMed ID: 18004003
    [No Abstract] [Full Text] [Related]

  • 46. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
    Liepe K, Brogsitter C, Leonhard J, Wunderlich G, Hliscs R, Pinkert J, Folprecht G, Kotzerke J.
    Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
    [Abstract] [Full Text] [Related]

  • 47. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe.
    Powerski MJ, Scheurig-Münkler C, Banzer J, Schnapauff D, Hamm B, Gebauer B.
    Eur J Radiol; 2012 Jul; 81(7):e804-11. PubMed ID: 22546235
    [Abstract] [Full Text] [Related]

  • 48. Posttreatment PET-CT-confirmed intrahepatic radioembolization performed without coil embolization, by using the antireflux Surefire Infusion System.
    van den Hoven AF, Prince JF, Samim M, Arepally A, Zonnenberg BA, Lam MG, van den Bosch MA.
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):523-8. PubMed ID: 23756882
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. No infectious hepatic complications following radioembolization with 90Y microspheres in patients with biliodigestive anastomosis.
    Geisel D, Powerski MJ, Schnapauff D, Collettini F, Thiel R, Denecke T, Wieners G, Gebauer B.
    Anticancer Res; 2014 Aug; 34(8):4315-21. PubMed ID: 25075065
    [Abstract] [Full Text] [Related]

  • 51. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N, Gordon F, Hodolic M, Al-Nahhas A, Wasan HS, Habib N, Tait NP.
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [Abstract] [Full Text] [Related]

  • 52. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R, Seidensticker M, Peters N, Mohnike K, Bornschein J, Schütte K, Amthauer H, Malfertheiner P, Pech M, Ricke J.
    Dig Dis; 2009 Apr; 27(2):189-99. PubMed ID: 19546558
    [Abstract] [Full Text] [Related]

  • 53. Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis?
    Pellerin O, Lin M, Bhagat N, Shao W, Geschwind JF.
    Cancer Biother Radiopharm; 2013 Apr; 28(6):459-65. PubMed ID: 23484809
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Efficacy of selective internal radioembolization with phosphorus-32 glass microspheres combining with hepatic arterial em bolization on advanced liver cancer].
    Zhang XR, Zheng L, Chen DF, Liu CY, Wang G.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):337. PubMed ID: 12837209
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery.
    Leong QM, Lai HK, Lo RG, Teo TK, Goh A, Chow PK.
    J Vasc Interv Radiol; 2009 Jun; 20(6):833-6. PubMed ID: 19406668
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P, Müller S, Hamami M, Sauerwein WS, Haberkorn U, Gerken G, Antoch G.
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [Abstract] [Full Text] [Related]

  • 60. Survival after accidental extrahepatic distribution of Y90 microspheres to the mesentery during a radioembolization procedure.
    Sabet A, Ahmadzadehfar H, Schäfer N, Wilhelm K, Schüller H, Ezziddin S.
    Cardiovasc Intervent Radiol; 2012 Aug; 35(4):954-7. PubMed ID: 22006030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.